VERV

Verve Therapeutics
VERV

Overview Fund Activity
Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

166 hedge funds and large institutions have $372M invested in Verve Therapeutics in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 64 increasing their positions, 47 reducing their positions, and 30 closing their positions.

Holders
166
Holders Change
+3
Holders Change %
+1.84%
% of All Funds
2.41%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
35
Increased
64
Reduced
47
Closed
30
Calls
$576K
Puts
$1M
Net Calls
-$428K
Net Calls Change
+$670K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$18.9M
2
BlackRock
2
BlackRock
New York
$32.3M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$4.42M
4
VPC
4
Vestal Point Capital
New York
$2.44M
5
Goldman Sachs
5
Goldman Sachs
New York
$6.29M

Top Sellers

1
AIM
1
ARK Investment Management
Florida
$14.3M
2
Federated Hermes
2
Federated Hermes
Pennsylvania
$5.62M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$6.91M
4
State Street
4
State Street
Massachusetts
$16.3M
5
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$5.44M
Name Market Value Shares Shares
Change 		Shares
Change %
AI
1
Alphabet Inc
California
$60.3M 12,349,086 – –
BlackRock
2
BlackRock
New York
$32.3M 6,620,004 +1,246,827 +23%
Vanguard Group
3
Vanguard Group
Pennsylvania
$25.7M 5,263,509 -1,067,803 -17%
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$22.1M 4,528,712 -47,712 -1%
Millennium Management
5
Millennium Management
New York
$18.9M 3,870,840 +3,256,410 +530%
State Street
6
State Street
Massachusetts
$16.3M 3,349,408 -1,748,000 -34%
CC
7
Casdin Capital
New York
$14.9M 3,059,094 – –
AIM
8
ARK Investment Management
Florida
$14.3M 2,936,063 -3,104,413 -51%
NHAS
9
Novo Holdings A/S
Denmark
$11.7M 2,400,000 +400,000 +20%
AVM
10
Arch Venture Management
Illinois
$9.8M 2,008,809 – –
BBA
11
Baker Bros. Advisors
New York
$8.25M 1,691,530 – –
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$8.25M 1,691,352 +198,302 +13%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$7.61M 1,559,772 +110,346 +8%
RG
14
Redmile Group
California
$7.14M 1,463,406 -141,109 -9%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$6.91M 1,415,120 -1,962,354 -58%
Goldman Sachs
16
Goldman Sachs
New York
$6.29M 1,288,249 +457,379 +55%
EC
17
EcoR1 Capital
California
$6.1M 1,250,000 – –
Federated Hermes
18
Federated Hermes
Pennsylvania
$5.62M 1,151,550 -2,405,027 -68%
Sumitomo Mitsui Trust Group
19
Sumitomo Mitsui Trust Group
Japan
$5.44M 1,115,466 -1,476,732 -57%
NAMA
20
Nikko Asset Management Americas
New York
$5.43M 1,115,466 -1,476,732 -57%
Jacobs Levy Equity Management
21
Jacobs Levy Equity Management
New Jersey
$4.42M 905,815 +905,815 New
Nuveen Asset Management
22
Nuveen Asset Management
Illinois
$3.96M 810,497 -64,722 -7%
BI
23
BVF Inc
California
$3.17M 650,000 – –
MB
24
MPM BioImpact
Massachusetts
$3.11M 638,163 – –
Morgan Stanley
25
Morgan Stanley
New York
$3.04M 623,730 -261,836 -30%
1
2 3 4 5